Frontiers in Immunology, 2022 · DOI: 10.3389/fimmu.2022.881162 · Published: May 20, 2022
Spinal cord injury (SCI) is a devastating neurological disorder often resulting in high mortality and disability. Effectively reducing pro-inflammatory responses is a promising treatment strategy to improve functional recovery after SCI. Olfactory ensheathing cells (OECs) have increasingly become potential candidates for cell-based therapy in the injured CNS because of their anti-inflammatory and immunoregulatory effects. A deeper understanding of OEC immunological functions may improve clinical applications of OECs for SCI. This review summarizes recent research on the cellular and molecular immune attributes of OECs, focusing on their unique biological functions in promoting neural regeneration to develop novel therapies for CNS injury.
OECs offer a potential target for cell-based therapies in treating spinal cord injuries by leveraging their anti-inflammatory and regenerative properties.
Understanding the immunomodulatory mechanisms of OECs can help develop strategies to control inflammation and promote a regenerative microenvironment in SCI.
Further research into OEC immunological functions can improve clinical applications and outcomes in SCI treatment through targeted therapies.